Latvia vs Malta: HICP - Tea, mate and other plant-derived products for infusion (ND)
Latvia
1.88
in 2026
Malta
2.41
in 2026
Latvia rank
4th
Malta rank
1st
HICP - Tea, mate and other plant-derived products for infusion (ND) over time
- Latvia
- Malta
How they compare
Malta currently reports 2.41 against 1.88 in Latvia, a difference of 0.53.
That makes Malta's figure about 1.3 times Latvia's.
The two have swapped places 5 times across 31 shared years of data; in 1996 it was Latvia ahead.
Latvia ranks 4th and Malta ranks 1st of 27 countries.
Latvia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Latvia | Malta | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 2.77 | 1.56 | 1.21 | Latvia |
| 2000s | 2.28 | 1.51 | 0.768 | Latvia |
| 2010s | 1.78 | 1.63 | 0.151 | Latvia |
| 2020s | 2.31 | 2 | 0.3086 | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hicp - tea, mate and other plant-derived products for infusion (nd), Latvia or Malta?
- Malta, at 2.41 against 1.88 in Latvia as of 2026.
- What is the difference in hicp - tea, mate and other plant-derived products for infusion (nd) between Latvia and Malta?
- 0.53, with Malta ahead.
- How many years of comparable data are there for Latvia and Malta?
- 31 years are reported by both, from 1996 to 2026.
- How do Latvia and Malta rank globally for hicp - tea, mate and other plant-derived products for infusion (nd)?
- Latvia ranks 4th and Malta ranks 1st of 27 countries.
- Where does this data come from?
- European Central Bank, published as HICP - Tea, mate and other plant-derived products for infusion (ND) (Neither seasonally nor working day adjusted, Sub-index weight). Statizoid refreshes it automatically from the source and publishes the full history for both places.